ANNEXON, INC. Earnings Per Share (Basic)
ANNEXON, INC. (ANNX) reported Earnings Per Share (Basic) of -$0.28 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- ANNEXON, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.28.
- ANNEXON, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.23.
- ANNEXON, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.28.
- ANNEXON, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.37.
- ANNEXON, INC. earnings per share, basic for fiscal 2025 was -$1.34.
- ANNEXON, INC. earnings per share, basic for fiscal 2024 was -$1.01.
- ANNEXON, INC. earnings per share, basic for fiscal 2023 was -$1.77.
- ANNEXON, INC. earnings per share, basic for fiscal 2022 was -$2.60.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.28 10-Q · filed 2026-08-12 | -$0.50 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | -$0.23 10-Q · filed 2026-05-07 | |||
| 2025-12-31 | -$0.28 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.64 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.98 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.34 10-K · filed 2026-03-30 |
| 2025-09-30 | -$0.37 10-Q · filed 2025-11-10 | -$0.71 derived: net income ÷ weighted average shares · filed 2026-08-12 | -$1.08 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$0.34 10-Q · filed 2026-08-12 | -$0.71 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | -$0.37 10-Q · filed 2026-05-07 | |||
| 2024-12-31 | -$0.31 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-03-30 | -$1.01 10-K · filed 2026-03-30 |
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-10 | -$0.48 derived: net income ÷ weighted average shares · filed 2025-11-10 | -$0.68 10-Q · filed 2025-11-10 | |
| 2024-06-30 | -$0.23 10-Q · filed 2025-08-14 | -$0.43 10-Q · filed 2025-08-14 | ||
| 2024-03-31 | -$0.21 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | -$1.77 10-K · filed 2025-03-03 | |||
| 2023-09-30 | -$0.43 10-Q · filed 2024-11-14 | -$1.42 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$0.47 10-Q · filed 2024-08-12 | -$0.99 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$0.52 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | -$0.47 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$0.98 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$1.78 derived: net income ÷ weighted average shares · filed 2024-03-26 | -$2.60 10-K · filed 2024-03-26 |
| 2022-09-30 | -$0.51 10-Q · filed 2023-11-13 | -$1.35 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$2.21 10-Q · filed 2023-11-13 | -$3.15 derived: net income ÷ weighted average shares · filed 2023-11-13 |
| 2022-06-30 | -$0.96 10-Q · filed 2023-08-07 | -$1.88 10-Q · filed 2023-08-07 | -$2.85 derived: net income ÷ weighted average shares · filed 2023-08-07 | -$3.78 derived: net income ÷ weighted average shares · filed 2023-08-07 |
| 2022-03-31 | -$0.92 10-Q · filed 2023-05-08 | -$1.89 derived: net income ÷ weighted average shares · filed 2023-05-08 | -$2.82 derived: net income ÷ weighted average shares · filed 2023-05-08 | -$3.63 derived: net income ÷ weighted average shares · filed 2023-05-08 |
| 2021-12-31 | -$0.97 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$1.90 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$2.72 derived: net income ÷ weighted average shares · filed 2023-03-06 | -$3.40 10-K · filed 2023-03-06 |
| 2021-09-30 | -$0.93 10-Q · filed 2022-11-03 | -$1.75 derived: net income ÷ weighted average shares · filed 2022-11-03 | -$2.43 10-Q · filed 2022-11-03 | |
| 2021-06-30 | -$0.82 10-Q · filed 2022-08-08 | -$1.50 10-Q · filed 2022-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |